Non-coding DNA reveals a route by which advanced prostate cancer resists treatment
Two research teams converge on epigenetic switches that feed treatment-resistant metastatic prostate tumors. This research highlights the value of exploring gene regulation and large-scale structural changes in the cancer genome.

Credit: Susanna M. Hamilton